RT Book, Section A1 Caley, Charles F. A2 Angaran, David M. A2 Whalen, Karen SR Print(0) ID 1102489747 T1 Schizophrenia Medication Therapy Management Data Set T2 Medication Therapy Management: A Comprehensive Approach YR 2015 FD 2015 PB McGraw-Hill Education PP New York, NY SN 9780071848695 LK accesspharmacy.mhmedical.com/content.aspx?aid=1102489747 RD 2024/03/29 AB Appropriate evaluation of schizophrenia includes assessment of patients' positive symptoms, negative symptoms, and severity of cognitive deficits. MTM providers working with patients with schizophrenia should be adequately trained in the use of common rating scales.MTM providers should educate patients to be realistic about the expected outcomes of antipsychotic therapy, ie, even when medication is taken as prescribed, there may be days when symptoms of schizophrenia may be bothersome.Nonadherence is a common medication-related problem among patients with schizophrenia. MTM providers should be vigilant for nonadherence and work with the patient and provider to find a regimen that promotes adherence and minimizes adverse effects along with drug costs.Metabolic syndrome and extrapyramidal symptoms are concerning adverse effects of antipsychotic drug therapy. MTM providers should monitor for these adverse effects and recommend appropriate changes in therapy to help minimize their consequences.